Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation
While promising, the technology has much to prove, including how much it really adds to standard risk prediction.
United States United Kingdom Agepha Pharma Viviany Taqueti Md University Of Oxford American Heart Association
Source: tctmd.com